Tag: docetaxelTaxotere

Articles

• Factors influencing Taxol (paclitaxel) effectiveness

News

03/11/18

Flaxseed lignans increase treatment effects of Adriamycin & Taxotere

12/16/17

Melatonin enhances the treatment effects of Taxotere in ER+/PR+ BC

03/12/17

Sulforaphane in broccoli heightens taxane effects against TN disease

Studies

• Therapeutic Applications of Rosmarinic Acid in Cancer-Chemotherapy-Associated Resistance and Toxicity Cite
  Villegas C, Cortez N, Ogundele AV, Burgos V, Pardi PC, Cabrera-Pardo JR, et al. Therapeutic Applications of Rosmarinic Acid in Cancer-Chemotherapy-Associated Resistance and Toxicity. Biomolecules. MDPI AG; 2024; 14:867 10.3390/biom14070867
• Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer Cite
  Otto-Dobos L, Grant C, Lahoud A, Wilcox O, Strehle L, Loman B, et al. Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer. Brain, Behavior, and Immunity. Elsevier BV; 2024; 120:208-220 10.1016/j.bbi.2024.05.039
• The Potential of Mushroom Extracts to Improve Chemotherapy Efficacy in Cancer Cells: A Systematic Review Cite
  Fonseca J, Vaz JA, Ricardo S. The Potential of Mushroom Extracts to Improve Chemotherapy Efficacy in Cancer Cells: A Systematic Review. Cells. MDPI AG; 2024; 13:510 10.3390/cells13060510
• Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review Cite
  Sailo BL, Liu L, Chauhan S, Girisa S, Hegde M, Liang L, et al. Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review. Cancers. MDPI AG; 2024; 16:244 10.3390/cancers16020244
• Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape Cite
  Ganesan R, Bhasin SS, Bakhtiary M, Krishnan U, Cheemarla NR, Thomas BE, et al. Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape. PLOS Biology. Public Library of Science (PLoS); 2023; 21:e3002275 10.1371/journal.pbio.3002275
• Effect of exercise before and/or during taxane-containing chemotherapy treatment on chemotherapy-induced peripheral neuropathy symptoms in women with breast cancer: systematic review and meta-analysis Cite
  Brownson-Smith R, Orange ST, Cresti N, Hunt K, Saxton J, Temesi J. Effect of exercise before and/or during taxane-containing chemotherapy treatment on chemotherapy-induced peripheral neuropathy symptoms in women with breast cancer: systematic review and meta-analysis. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2023; 10.1007/s11764-023-01450-w
• Short-term fasting and fasting mimicking diets combined with chemotherapy: a narrative review Cite
  Kikomeko J, Schutte T, van Velzen MJ, Seefat R, van Laarhoven HW. Short-term fasting and fasting mimicking diets combined with chemotherapy: a narrative review. Therapeutic Advances in Medical Oncology. SAGE Publications; 2023; 15:175883592311614 10.1177/17588359231161418
• Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714. Cite
  Trivedi MS, Unger JM, Hershman DL, Darke A, Hertz DL, Brannagan T, et al. Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2023; 41:12003-12003 10.1200/jco.2023.41.16_suppl.12003
• Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer Cite
  Pleasant VA, Purkiss AS, Merjaver SD. Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer. Cancer. Wiley; 2023; 129:1629-1633 10.1002/cncr.34732
• A review of the pharmacodynamic effect of chemo-herbal drug combinations therapy for cancer treatment Cite
  Okem A, Henstra C, Lambert M, Hayeshi R. A review of the pharmacodynamic effect of chemo-herbal drug combinations therapy for cancer treatment. Medicine in Drug Discovery. Elsevier BV; 2023; 17:100147 10.1016/j.medidd.2022.100147
• The Self-Administered Use of Complementary and Alternative Medicine (CAM) Supplements and Antioxidants in Cancer Therapy and the Critical Role of Nrf-2—A Systematic Review Cite
  Krejbich P, Birringer M. The Self-Administered Use of Complementary and Alternative Medicine (CAM) Supplements and Antioxidants in Cancer Therapy and the Critical Role of Nrf-2—A Systematic Review. Antioxidants. MDPI AG; 2022; 11:2149 10.3390/antiox11112149
• Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells Cite
  O’Grady S, Crown J, Duffy MJ. Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells. Medical Oncology. Springer Science and Business Media LLC; 2022; 39 10.1007/s12032-022-01733-9
• Can Exposure to Environmental Pollutants Be Associated with Less Effective Chemotherapy in Cancer Patients? Cite
  Lagunas-Rangel FA, Liu W, Schiöth HB. Can Exposure to Environmental Pollutants Be Associated with Less Effective Chemotherapy in Cancer Patients?. International Journal of Environmental Research and Public Health. MDPI AG; 2022; 19:2064 10.3390/ijerph19042064
• The effect of trastuzumab on taxane-induced peripheral neuropathy in women with breast cancer: a population-based cohort study Cite
  Patel R, Lyne-Ethier J, Brogly S, Griffiths R, Hendry JM. The effect of trastuzumab on taxane-induced peripheral neuropathy in women with breast cancer: a population-based cohort study. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1254626/v1
• Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis Cite
  Small BJ, Lange M, Zhai W, Ahn J, Ahles TA, Carroll JE, et al. Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06455-6
• Revisiting the Anticancer Drug–Food Interactions Cite
  Gacche RN. Revisiting the Anticancer Drug–Food Interactions. Dietary Research and Cancer. Springer Singapore; 2021;:113-120 10.1007/978-981-16-6050-4_11
• A careful reassessment of anthracycline use in curable breast cancer Cite
  Hurvitz SA, McAndrew NP, Bardia A, Press MF, Pegram M, Crown JP, et al. A careful reassessment of anthracycline use in curable breast cancer. npj Breast Cancer. Springer Science and Business Media LLC; 2021; 7 10.1038/s41523-021-00342-5
• Focal white matter microstructural alteration after anthracycline-based systemic treatment in long-term breast cancer survivors: a structural magnetic resonance imaging study Cite
  Zhang H, Li P, Liu T, Wang X, Feng W, Chen R, et al. Focal white matter microstructural alteration after anthracycline-based systemic treatment in long-term breast cancer survivors: a structural magnetic resonance imaging study. Brain Imaging and Behavior. Springer Science and Business Media LLC; 2021; 10.1007/s11682-021-00551-3
• Cognitive Impairment Resulting from Treatment with Docetaxel, Doxorubicin, and Cyclophosphamide Cite
  Brown T, McElroy T, Simmons P, Walters H, Ntagwabira F, Wang J, et al. Cognitive Impairment Resulting from Treatment with Docetaxel, Doxorubicin, and Cyclophosphamide. Brain Research. Elsevier BV; 2021;:147397 10.1016/j.brainres.2021.147397
• Scalp cooling in breast cancer patients treated with docetaxel–cyclophosphamide: patient- and nurse-reported results Cite
  Coolbrandt A, T’Jonck A, Blauwens K, Dejaeger E, Neven P, Punie K, et al. Scalp cooling in breast cancer patients treated with docetaxel–cyclophosphamide: patient- and nurse-reported results. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-020-06063-w
• Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres Cite
  Chan J, Adderley H, Alameddine M, Armstrong A, Arundell D, Fox R, et al. Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres. European Journal of Cancer Care. Wiley; 2020; 10.1111/ecc.13395
• Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer Cite
  Pabst L, Velten M, Fischbach C, Kalish M, Pflumio C, Pivot X, et al. Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer. The Breast Journal. Wiley; 2020; 26:2376-2382 10.1111/tbj.14123
• Impact of Exercise on Chemotherapy Tolerance and Survival in Early-Stage Breast Cancer: A Nonrandomized Controlled Trial Cite
  Kirkham AA, Gelmon KA, Van Patten CL, Bland KA, Wollmann H, McKenzie DC, et al. Impact of Exercise on Chemotherapy Tolerance and Survival in Early-Stage Breast Cancer: A Nonrandomized Controlled Trial. Journal of the National Comprehensive Cancer Network. Harborside Press, LLC; 2020; 18:1670-1677 10.6004/jnccn.2020.7603
• Scalp Cooling Impact in Alopecia of Patients Under Treatment for Breast Cancer—Literature Review Cite
  Wiethan GÁ, Sari MHM, Ferreira LM. Scalp Cooling Impact in Alopecia of Patients Under Treatment for Breast Cancer—Literature Review. SN Comprehensive Clinical Medicine. Springer Science and Business Media LLC; 2020; 2:2825-2833 10.1007/s42399-020-00653-x
• Docetaxel Loaded Pomegranate Seed Oil Based Nanostructured Lipid Carriers: A Potential Alternative to Current Formulation Cite
  Talkar SS, Kharkar PB, Patravale VB. Docetaxel Loaded Pomegranate Seed Oil Based Nanostructured Lipid Carriers: A Potential Alternative to Current Formulation. AAPS PharmSciTech. Springer Science and Business Media LLC; 2020; 21 10.1208/s12249-020-01839-1
• Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells Cite
  Alkhatib MH, Bawadud RS, Gashlan HM. Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells. Scientific Reports. Springer Science and Business Media LLC; 2020; 10 10.1038/s41598-020-75017-5
• Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index Cite
  Desmedt C, Fornili M, Clatot F, Demicheli R, De Bortoli D, Di Leo A, et al. Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:2883-2891 10.1200/jco.19.01771
• Obesity-Associated Leptin Signaling Promotes Chemotherapy Resistance in Basal-Like Breast Cancer: The Role of Tumor-Associated Macrophages Cite
  Bowers L, Kulkarni A, Hursting S. Obesity-Associated Leptin Signaling Promotes Chemotherapy Resistance in Basal-Like Breast Cancer: The Role of Tumor-Associated Macrophages. Current Developments in Nutrition. Oxford University Press (OUP); 2020; 4:311-311 10.1093/cdn/nzaa044_010
• Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process Cite
  González-González A, González A, Rueda N, Alonso-González C, Menéndez JM, Martínez-Campa C, et al. Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process. Scientific Reports. Springer Science and Business Media LLC; 2020; 10 10.1038/s41598-020-61622-x
• Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems Cite
  Kamal MM, Akter S, Lin C, Nazzal S. Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems. Archives of Pharmacal Research. Springer Science and Business Media LLC; 2020; 43:371-384 10.1007/s12272-020-01225-2
• Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer Cite
  Cespedes Feliciano EM, Chen WY, Lee V, Albers KB, Prado CM, Alexeeff S, et al. Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer. JAMA Oncology. American Medical Association (AMA); 2020; 6:264 10.1001/jamaoncol.2019.4668
• Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity Cite
  Zafar S, Akhter S, Garg N, Selvapandiyan A, Kumar Jain G, Ahmad FJ. Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity. European Journal of Pharmaceutics and Biopharmaceutics. Elsevier BV; 2020; 148:10-26 10.1016/j.ejpb.2019.12.016
• Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel Cite
  Odeh F, Naffa R, Azzam H, Mahmoud IS, Alshaer W, Al Bawab A, et al. Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel. Heliyon. Elsevier BV; 2019; 5:e02919 10.1016/j.heliyon.2019.e02919
• Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies Cite
  Zafar S, Akhter S, Ahmad I, Hafeez Z, Alam Rizvi MM, Jain GK, et al. Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies. Colloids and Surfaces B: Biointerfaces. Elsevier BV; 2020; 186:110603 10.1016/j.colsurfb.2019.110603
• Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts Cite
  Newell M, Goruk S, Mazurak V, Postovit L, Field CJ. Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 177:357-367 10.1007/s10549-019-05331-8
• A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients Cite
  Watanabe T, Yagata H, Saito M, Okada H, Yajima T, Tamai N, et al. A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients. PLOS ONE. Public Library of Science (PLoS); 2019; 14:e0208118 10.1371/journal.pone.0208118
• Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population Cite
  Greenwald MK, Ruterbusch JJ, Beebe-Dimmer JL, Simon MS, Albrecht TL, Schwartz AG. Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population. Cancer. Wiley; 2018; 125:269-277 10.1002/cncr.31798
• Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221) Cite
  Mongiovi JM, Zirpoli GR, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, et al. Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221). Breast Cancer Research. Springer Science and Business Media LLC; 2018; 20 10.1186/s13058-018-1077-9
• Permanent Chemotherapy‐Induced Alopecia in Patients with Breast Cancer: A 3‐Year Prospective Cohort Study Cite
  Kang D, Kim I, Choi E, Im YH, Park YH, Ahn JS, et al. Permanent Chemotherapy‐Induced Alopecia in Patients with Breast Cancer: A 3‐Year Prospective Cohort Study. The Oncologist. Wiley; 2018; 24:414-420 10.1634/theoncologist.2018-0184
• Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens Cite
  Chan A, Bauwens A, Pontre S, Jackson S, McGlone F, Ernenwein T, et al. Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens. The Breast. Elsevier BV; 2018; 41:127-132 10.1016/j.breast.2018.07.006
• Abstract 2934: Cucurbitacin D enhances the therapeutic efficacy of docetaxel via targeting cancer stem cells and miR-145 Cite
  Sikander M, Malik S, Hafeez BB, Mandil H, Halaweish FT, Jaggi M, et al. Abstract 2934: Cucurbitacin D enhances the therapeutic efficacy of docetaxel via targeting cancer stem cells and miR-145. Experimental and Molecular Therapeutics. American Association for Cancer Research; 2018; 10.1158/1538-7445.am2018-2934
• Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling Cite
  Martín M, de la Torre-Montero JC, López-Tarruella S, Pinilla K, Casado A, Fernandez S, et al. Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 171:627-634 10.1007/s10549-018-4855-2
• Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms Cite
  Gong X, Smith J, Swanson H, Rubin L. Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms. Molecules. MDPI AG; 2018; 23:905 10.3390/molecules23040905
• Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study Cite
  Fernandes R, Mazzarello S, Joy AA, Pond GR, Hilton J, Ibrahim MFK, et al. Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study. Supportive Care in Cancer. Springer Science and Business Media LLC; 2018; 26:3073-3081 10.1007/s00520-018-4161-x
• Flaxseed Lignans Enhance the Cytotoxicity of Chemotherapeutic Agents against Breast Cancer Cell Lines MDA-MB-231 and SKBR3 Cite
  Di Y, De Silva F, Krol ES, Alcorn J. Flaxseed Lignans Enhance the Cytotoxicity of Chemotherapeutic Agents against Breast Cancer Cell Lines MDA-MB-231 and SKBR3. Nutrition and Cancer. Informa UK Limited; 2018; 70:306-315 10.1080/01635581.2018.1421677
• Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema Cite
  Lim H, Kim KM, Jeong S, Choi EK, Jung J. Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema. Integrative Cancer Therapies. SAGE Publications; 2016; 16:496-504 10.1177/1534735416645184
• Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30 Cite
  Bandos H, Melnikow J, Rivera DR, Swain SM, Sturtz K, Fehrenbacher L, et al. Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2017; 110 10.1093/jnci/djx162
• Co-delivery of docetaxel and silibinin using pH-sensitive micelles improves therapy of metastatic breast cancer Cite
  Dong X, Lang T, Yin Q, Zhang P, Li Y. Co-delivery of docetaxel and silibinin using pH-sensitive micelles improves therapy of metastatic breast cancer. Acta Pharmacologica Sinica. Springer Science and Business Media LLC; 2017; 38:1655-1662 10.1038/aps.2017.74
• Two-year trends of taxane-induced neuropathy in women enrolled in a randomized trial of acetyl-l-carnitine (SWOG S0715). Cite
  Hershman DL, Unger JM, Crew KD, Ebnesajjad C, Greenlee H, Fehrenbacher L, et al. Two-year trends of taxane-induced neuropathy in women enrolled in a randomized trial of acetyl-l-carnitine (SWOG S0715).. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:10093-10093 10.1200/jco.2017.35.15_suppl.10093
• Docetaxel does not impair skeletal muscle force production in a murine model of cancer chemotherapy Cite
  Chaillou T, McPeek A, Lanner JT. Docetaxel does not impair skeletal muscle force production in a murine model of cancer chemotherapy. Physiological Reports. Wiley; 2017; 5:e13261 10.14814/phy2.13261
• Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study Cite
  Cerulla N, Arcusa À, Navarro J, Garolera M, Enero C, Chico G, et al. Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 164:179-187 10.1007/s10549-017-4240-6
• Chemotherapy-induced irreversible alopecia in early breast cancer patients Cite
  Kim GM, Kim S, Park HS, Kim JY, Nam S, Park S, et al. Chemotherapy-induced irreversible alopecia in early breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 163:527-533 10.1007/s10549-017-4204-x
• Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients Cite
  Fonia A, Cota C, Setterfield JF, Goldberg LJ, Fenton DA, Stefanato CM. Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients. Journal of the American Academy of Dermatology. Elsevier BV; 2017; 76:948-957 10.1016/j.jaad.2016.12.027
• Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells Cite
  Burnett JP, Lim G, Li Y, Shah RB, Lim R, Paholak HJ, et al. Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells. Cancer Letters. Elsevier BV; 2017; 394:52-64 10.1016/j.canlet.2017.02.023
• Enhanced oral bioavailability of docetaxel in rats combined with myricetin: In situ and in vivo evidences Cite
  Hao T, Ling Y, Wu M, Shen Y, Gao Y, Liang S, et al. Enhanced oral bioavailability of docetaxel in rats combined with myricetin: In situ and in vivo evidences. European Journal of Pharmaceutical Sciences. Elsevier BV; 2017; 101:71-79 10.1016/j.ejps.2017.02.009
• A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes Cite
  Ratanajarusiri T, Sriuranpong V, Sitthideatphaiboon P, Poovoravan N, Vinayanuwat C, Parinyanitikul N, et al. A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes. Chemotherapy. S. Karger AG; 2016; 62:134-139 10.1159/000450748
• BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study Cite
  Greenlee H, Hershman DL, Shi Z, Kwan ML, Ergas IJ, Roh JM, et al. BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study. Journal of the National Cancer Institute. Oxford University Press (OUP); 2016; 109:djw206 10.1093/jnci/djw206
• Abstract 3841: Curcumin enhances the efficacy of docetaxel- induced apoptosis of prostate cancer cell Cite
  Banerjee S, Singh SK, Lillard JW, Singh R. Abstract 3841: Curcumin enhances the efficacy of docetaxel- induced apoptosis of prostate cancer cell. Experimental and Molecular Therapeutics. American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-3841
• Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review Cite
  Fernandes R, Mazzarello S, Hutton B, Shorr R, Majeed H, Ibrahim MF, et al. Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review. Supportive Care in Cancer. Springer Science and Business Media LLC; 2016; 24:3633-3650 10.1007/s00520-016-3256-5
• The Use of Complementary and Alternative Medicine Supplements of Potential Concern during Breast Cancer Chemotherapy Cite
  Sweet E, Dowd F, Zhou M, Standish LJ, Andersen MR. The Use of Complementary and Alternative Medicine Supplements of Potential Concern during Breast Cancer Chemotherapy. Evidence-Based Complementary and Alternative Medicine. Hindawi Limited; 2016; 2016:1-8 10.1155/2016/4382687
• Resveratrol chemosensitizes HER-2-overexpressing breast cancer cells to docetaxel chemoresistance by inhibiting docetaxel-mediated activation of HER-2–Akt axis Cite
  Vinod BS, Nair HH, Vijayakurup V, Shabna A, Shah S, Krishna A, et al. Resveratrol chemosensitizes HER-2-overexpressing breast cancer cells to docetaxel chemoresistance by inhibiting docetaxel-mediated activation of HER-2–Akt axis. Cell Death Discovery. Springer Science and Business Media LLC; 2015; 1 10.1038/cddiscovery.2015.61
• The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study Cite
  de Groot S, Vreeswijk MP, Welters MJ, Gravesteijn G, Boei JJ, Jochems A, et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer. Springer Science and Business Media LLC; 2015; 15 10.1186/s12885-015-1663-5
• Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer Cite
  Patel K, Chowdhury N, Doddapaneni R, Boakye CH, Godugu C, Singh M. Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer. Journal of Pharmaceutical Sciences. Elsevier BV; 2015; 104:4417-4426 10.1002/jps.24637
• Taxane induced neuropathy in patients affected by breast cancer: Literature review Cite
  De Iuliis F, Taglieri L, Salerno G, Lanza R, Scarpa S. Taxane induced neuropathy in patients affected by breast cancer: Literature review. Critical Reviews in Oncology/Hematology. Elsevier BV; 2015; 96:34-45 10.1016/j.critrevonc.2015.04.011
• Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer Cite
  Barcenas CH, Niu J, Zhang N, Zhang Y, Buchholz TA, Elting LS, et al. Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014; 32:2010-2017 10.1200/jco.2013.49.3676
• Thymoquinone, A Bioactive Component of Black Caraway Seeds, Causes G1 Phase Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells with Mutant p53 Cite
  Sutton KM, Greenshields AL, Hoskin DW. Thymoquinone, A Bioactive Component of Black Caraway Seeds, Causes G1 Phase Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells with Mutant p53. Nutrition and Cancer. Informa UK Limited; 2014; 66:408-418 10.1080/01635581.2013.878739
• Metabolomics Reveals Metabolic Targets and Biphasic Responses in Breast Cancer Cells Treated by Curcumin Alone and in Association with Docetaxel Cite
  Bayet-Robert M, Morvan D. Metabolomics Reveals Metabolic Targets and Biphasic Responses in Breast Cancer Cells Treated by Curcumin Alone and in Association with Docetaxel. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e57971 10.1371/journal.pone.0057971
• The depletion of Interleukin-8 causes cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells Cite
  Shao N, Chen L, Ye R, Lin Y, Wang S. The depletion of Interleukin-8 causes cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells. Biochemical and Biophysical Research Communications. Elsevier BV; 2013; 431:535-541 10.1016/j.bbrc.2013.01.022
• The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer Cite
  Aribi A, Gery S, Lee DH, Thoennissen NH, Thoennissen GB, Alvarez R, et al. The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer. International Journal of Cancer. Wiley; 2012; 132:2730-2737 10.1002/ijc.27950
• Surgery for widely disseminated breast cancer: prolonged control by excision of metastases Cite
  Rees GJ, Britton DC, Malcolm GP, Rees M. Surgery for widely disseminated breast cancer: prolonged control by excision of metastases. JRSM Short Reports. SAGE Publications; 2012; 3:1-4 10.1258/shorts.2012.011162
• Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel Cite
  Berliere M, Dalenc F, Malingret N, Vindevogel A, Piette P, Roche H, et al. Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel. BMC Cancer. Springer Science and Business Media LLC; 2008; 8 10.1186/1471-2407-8-56
• Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer Cite
  Swain SM, Jeong J, Geyer CE, Costantino JP, Pajon ER, Fehrenbacher L, et al. Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer. New England Journal of Medicine. Massachusetts Medical Society; 2010; 362:2053-2065 10.1056/nejmoa0909638
• Adjuvant Trastuzumab in HER2-Positive Breast Cancer Cite
  Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, et al. Adjuvant Trastuzumab in HER2-Positive Breast Cancer. New England Journal of Medicine. Massachusetts Medical Society; 2011; 365:1273-1283 10.1056/nejmoa0910383
• Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity Cite
  Makhov P, Golovine K, Canter D, Kutikov A, Simhan J, Corlew MM, et al. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity. The Prostate. Wiley; 2011; 72:661-667 10.1002/pros.21469
• Abstract P3-15-05: Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy Cite
  van Draanen J, Stacey E, Dent R, Gallo-Hershberg D, Pasetka M, Giotis A, et al. Abstract P3-15-05: Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy. Poster Session Abstracts. American Association for Cancer Research; 2010; 10.1158/0008-5472.sabcs10-p3-15-05
• Hematologic toxicity with adjuvant docetaxel and cyclophosphamide in early breast cancer. Cite
  Santos FN, Cruz MR, Cezana L, Costa LA, de Azevedo CA, De Barros E Silva MJ, et al. Hematologic toxicity with adjuvant docetaxel and cyclophosphamide in early breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:e11081-e11081 10.1200/jco.2010.28.15_suppl.e11081
• Hepatotoxicity in breast cancer patients post-chemotherapy with docetaxel, doxorubucin, and cyclophosphamide. Cite
  Wills SM, Reid R, Jaiyesimi IA, Margolis JH. Hepatotoxicity in breast cancer patients post-chemotherapy with docetaxel, doxorubucin, and cyclophosphamide.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:e11031-e11031 10.1200/jco.2010.28.15_suppl.e11031
• Prognostic Significance of Neutropenia on Day One of Anthracycline-Based Neoadjuvant Chemotherapy in Operable Breast Cancer Cite
  Ishitobi M, Komoike Y, Motomura K, Koyama H, Inaji H. Prognostic Significance of Neutropenia on Day One of Anthracycline-Based Neoadjuvant Chemotherapy in Operable Breast Cancer. Oncology. S. Karger AG; 2010; 78:213-219 10.1159/000313702
• 3,3′-diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1 Cite
  Ahmad A, Ali S, Wang Z, Ali AS, Sethi S, Sakr WA, et al. 3,3′-diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1. International Journal of Cancer. Wiley; 2011; 129:1781-1791 10.1002/ijc.25839
• Exogenous supplementation with ω-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells Cite
  Menendez JA, Lupu R, Colomer R. Exogenous supplementation with ω-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells. European Journal of Cancer Prevention. Ovid Technologies (Wolters Kluwer Health); 2005; 14:263-270 10.1097/00008469-200506000-00011
• Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane Cite
  Azarenko O, Okouneva T, Singletary KW, Jordan MA, Wilson L. Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane. Carcinogenesis. Oxford University Press (OUP); 2008; 29:2360-2368 10.1093/carcin/bgn241